Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical dutasteride emulsion in men with androgenetic alopecia
2022-001802-23Phase 2Active
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of dutasteride in androgenetic alopecia (AGA), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Primary endpoint: Local adverse events and systemic adverse reactions. Started Jul 2022; status: active.
02
Drugs
dutasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on 2022-001802-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001802-23.